SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Adeshwar Meditex Ltd (543309)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543309 NSE: Pharmaceuticals & Drugs | Small Cap | Adeshwar Meditex Share Price

₹18.41 0.00 (0.00%)

As on 27-May'26 16:59

Adeshwar Meditex Ltd (543309)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543309 NSE: Pharmaceuticals & Drugs | Small Cap | Adeshwar Meditex Share Price

₹18.41 0.00 (0.00%)

As on 27-May'26 16:59

Key Metrics
Valuation Multiples
Market Cap
₹27 Cr.
Current Price
₹18.4
52-Week Low / High
₹13 / 22
TTM EPS
₹0.9
TTM Sales
₹56.1 Cr.
Book Value per Share
₹25.6
P/E Ratio
20.99
Higher than its 5-year historical median
Industry PE
46.5
Price to Book (P/B)
0.72
Lower than its 5-year historical median
Price to Sales (P/S)
0.47
In line with its 5-year historical median
EV/EBITDA
12.62
Higher than its 5-year historical median
Dividend Yield
0.00%
Profitability Efficiency
Return on Equity (ROE)
5.75%
Underperforms industry median
Return on Capital Employed (ROCE)
8.53%
Underperforms industry median
Return on Assets (ROA)
3.04%
Operating Profit Margin
5.3%
Net Profit Margin
2.47%
Gross Profit Margin
3.9%
Growth Momentum
1-yr vs 3-yr growth
Sales Growth (1 Year)
Slowing versus 3-year growth rate
4.83%
Operating Profit Growth (1 Year)
Slowing versus 3-year growth rate
-14.48%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
2.99%
Asset Quality
Promoter Holding
57.68%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
₹23 Cr.
Equity
₹14.4 Cr.
Face Value
₹10
All Time Low / High
₹13.30 / 42.00

Adeshwar Meditex stock performance

Key Ratios
mw4me loader

Check Before You Invest

M-Cap below 100cr DeciZen not available

Q.1 Is Adeshwar Meditex Ltd a good quality company?
Adeshwar Meditex Ltd is a quality company, based on a multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

  • How has it performed on generating Profits?

    By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.

  • How efficiently has it utilized Capital?

    By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.

  • How is it managing its Debt?

    By checking its Debt to Equity and Cash Flow from Operations.

How does Adeshwar Meditex Ltd performance compare with that of its Peers?
Q.1 Revenue growth of Adeshwar Meditex Ltd vs industry peers?
Adeshwar Meditex Ltd revenue CAGR is 8.33%, compared to the industry median CAGR of 5.35%, indicating faster growth and gaining its market share.
Q.1 Promoter shareholding and pledge status of Adeshwar Meditex Ltd?
Promoters hold 57.68% of the Adeshwar Meditex Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Q.1 Stock return of Adeshwar Meditex Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of -9.11% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Adeshwar Meditex Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good

Value Creation

Mar'15Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
ROCE % 16.8%0%28.8%17.6%14.3%11.1%7%10.1%9.6%8.5%-
Value Creation
Index
0.2NA1.10.30.0-0.2-0.5-0.3-0.3-0.4-

Growth Parameters

Sales 25.2058.652.956.16664.882.479.983.756
Sales YoY Gr.--100%NA-9.7%6.1%17.6%-1.8%27.2%-3.1%4.8%-
Adj EPS 1.502.62.221.50.51.41.41.40.9
YoY Gr.--100%NA-15.2%-9.6%-22.8%-65.1%164.2%0%1.4%-
BVPS (₹) 8.9013.615.935.919.521.522.824.225.625.6
Adj Net
Profit
102.62.22.11.60.8222.11
Cash Flow from Ops. 00-1.2-5.9-13.2-2.45.83.83.8-
Debt/CF from Ops. 00-9.9-3.4-21.57.1-7.82.93.63.3-

CAGR

9 Years 5 Years 3 Years 1 Years
Sales 14.3%8.3%8.9%4.8%
Adj EPS -0.8%-6.3%38.9%1.4%
BVPS12.5%-6.5%6.1%5.9%
Share Price - - -8.7% 1.2%

Key Financial Parameters

Mar'15Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25TTM
Return on
Equity %
17.9026.314.8128.136.365.73.4
Op. Profit
Mgn %
7.509.47.39.87.15.26.36.55.3NAN
Net Profit
Mgn %
4.104.44.13.72.41.22.52.52.42.3
Debt to
Equity
0.900.91.31.11.10.60.50.40.3-
Working Cap
Days
18201312382943033562852752730
Cash Conv.
Cycle
830771551741862001531631620

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Sales16.2825.1958.6052.9256.1265.9764.7682.3679.8583.71
Operating Expenses + 14.4723.3053.0849.0450.6361.2661.3677.1474.6779.29
Manufacturing Costs1.960.96002.100.811.151.3410.94
Material Costs9.9719.3247.9143.6742.2154.6654.8969.5069.8174.42
Employee Cost 1.061.431.872.261.171.511.331.331.161.40
Other Costs 1.481.603.303.105.154.283.994.972.702.53
Operating Profit 1.821.895.523.885.484.713.405.225.184.43
Operating Profit Margin (%) 11.2%7.5%9.4%7.3%9.8%7.1%5.2%6.3%6.5%5.3%
Other Income + 0.120.320.101.820.280.270.230.310.130.26
Exceptional Items 00-00000000
Interest 0.550.571.662.232.522.292.052.091.931.39
Depreciation 0.440.380.370.350.340.350.380.530.600.50
Profit Before Tax 0.951.253.583.122.912.341.192.902.792.79
Tax 0.370.221.020.870.790.660.400.830.780.73
Profit After Tax 0.581.042.562.252.121.680.792.072.012.07
PAT Margin (%) 3.5%4.1%4.4%4.3%3.8%2.5%1.2%2.5%2.5%2.5%
Adjusted EPS (₹)0.91.62.62.32.01.60.61.41.41.4
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Valuation of Adeshwar Meditex - Standalone

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

YTD 1Y 3Y 5Y 10Y Max
mw4me loader

mw4me loader

Analyst's Notes

data not found
No data found!

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25

Equity and Liabilities

Shareholders Fund + 5.505.9113.5515.8018.9020.5830.9532.9134.9136.96
Share Capital 2.852.854.984.985.2710.5314.4314.4314.4314.43
Reserves 2.653.068.5710.8213.6410.0516.5218.4820.4822.53
Debt +4.855.4411.4719.9221.3220.4017.2414.5212.7911.88
Long Term Debt2.241.670.5556.135.364.072.321.061.94
Short Term Debt2.603.7710.9214.9215.1915.0413.1712.2111.739.94
Minority Interest0000000000
Trade Payables3.143.045.996.8512.7117.9520.8316.7914.5321.21
Others Liabilities 2.011.581.701.191.793.253.422.671.741.91
Total Liabilities 15.4915.9732.7143.7654.7362.1772.4566.8963.9671.97

Fixed Assets

Net Fixed Assets +3.232.622.352.422.282.243.033.703.532.95
Gross Block5.555.896.426.857.037.358.539.7310.1610.01
Accumulated Depreciation2.323.264.074.424.745.115.506.036.637.05
CWIP 0000000000
Investments 000.020.040.080.080.100.100.100
Inventories5.294.908.4613.4714.4926.1125.3024.3226.5325.82
Trade Receivables3.844.2417.4519.6427.8727.2632.4827.9325.2734.98
Cash Equivalents 0.210.251.341.391.731.071.921.901.162.81
Others Assets 2.923.963.096.808.275.419.618.937.385.40
Total Assets 15.4915.9732.7143.7654.7362.1772.4566.8963.9671.97

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Cash Flow From Operating Activity + 00-1.17-5.87-0.993.15-2.445.773.843.80
PBT 003.583.122.912.341.192.902.792.79
Adjustment 001.942.442.802.352.282.322.191.60
Changes in Working Capital 00-5.64-10.56-5.88-0.83-5.341.48-0.330.25
Tax Paid 00-1.05-0.88-0.82-0.71-0.56-0.94-0.81-0.84
Cash Flow From Investing Activity + 000.07-0.301.58-0.71-1.16-1.16-0.220.51
Capex 00-0.01-0.42-0.18-0.32-1.17-1.20-0.430.07
Net Investments 00-0.02-0.02-0.04-0-0.02000.10
Others 000.100.141.81-0.380.030.040.210.34
Cash Flow From Financing Activity + 001.226.22-0.07-3.114.44-4.62-4.36-2.66
Net Proceeds from Shares 001.450109.75000
Net Proceeds from Borrowing 00001.13-0.77-1.29-1.76-1.260.88
Interest Paid 00-1.66-2.23-2.46-2.01-1.91-1.91-1.72-1.16
Dividend Paid 0000000000
Others 001.448.450.27-0.32-2.11-0.96-1.39-2.38
Net Cash Flow 000.110.050.53-0.660.85-0.02-0.751.65

Financial Ratio

PARTICULARSMar'14Mar'15Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24Mar'25
Ratios
ROE (%)11.3118.1726.3315.3412.198.53.086.55.925.75
ROCE (%)15.7216.7528.7617.5914.2911.136.9810.069.68.53
Asset Turnover Ratio1.081.62.411.381.141.130.961.181.221.23
PAT to CFO Conversion(x)00-0.46-2.61-0.471.88-3.092.791.911.84
Working Capital Days
Receivable Days85.7058.6067.60127.90154.50152.50168.40133.90121.60131.40
Inventory Days112.9073.8041.6075.6090.90112.30144.90110116.20114.10
Payable Days130.8058.5034.4053.7084.60102.40128.9098.8081.9087.70

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

Adeshwar Meditex Ltd FAQs

The current trading price of Adeshwar Meditex on 27-May-2026 16:59 is ₹18.41.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 26-May-2026 the market cap of Adeshwar Meditex stood at ₹26.57 Cr

The latest P/E ratio of Adeshwar Meditex as of 26-May-2026 is 20.99.

The latest P/B ratio of Adeshwar Meditex as of 26-May-2026 is 0.72.

The 52-week high of Adeshwar Meditex is ₹21.80 and the 52-week low is ₹13.30.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Adeshwar Meditex is ₹56.10 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that Adeshwar Meditex Ltd is a average quality company.

The key valuation ratios of Adeshwar Meditex Ltd's currently when compared to its past seem to suggest it is in the Undervalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Adeshwar Meditex Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About Adeshwar Meditex Ltd

Adeshwar Meditex is an Indian company, engaged in the manufacturing of surgical dressings and external preparations products of Wound care & Wound management including sterile surgical wound dressing, tulle dressing, medical disposable, adhesive bandages, absorbent gauze, plaster, disinfectants, medical kits etc. The company is an ISO 13485:2016 certified Company. It has manufacturing facility situated at Deewan Industrial Estate, Palghar District. Its state-of-the-art manufacturing plant follows WHO-GMP, CE, ISO guidelines and it is backed by an advanced production facility, which is fitted with latest machinery and well organized and arranged sterilization facilities.

It endeavors to maintain safety in its premises by adhering to key safety norms. Its manufacturing facility also has sophisticated facilities for quality testing, research & development, storage and packaging. It has an in-house R&D facility for on-site process improvement and for bettering its present products offered as well as products under innovation and testing laboratory which ensures that its products are certified and any major defects in the products are identified on real time basis and rectified before the final dispatch. It has dedicated teams actively involved in R&D and QC/ QA Lab activities. These functions have impeccably streamlined and thus assure swift production and post-production processes and enable it to support its growth strategy by developing new products and processes which enhance its product range. The focus of its R&D has been to strive for continuous process improvements which will cater to the requirements of global patients from the point of view of effectiveness and safety besides achieving manufacturing cost efficiencies.

Business area of the company

The company is one of the major, trusted, cGMP, CE, ISO 9001-2008 Certified manufacturer and exporter in the field of sterile surgical wound dressing products and medical disposables.

Major events in the history:

  • 1997: Started business as prop. Concern Adeshwar Meditex.
  • 2007: Incorporation of the Company and subsequently takeover of Proprietorship firm of our promoter Siddharth Talati, Adeshwar Meditex.
  • 2015: The company Crossed turnover of Rs 25 crore.
  • 2018: The company Crossed turnover of Rs 50 crore.
  • 2021: Conversion of Company from “Private Limited” to “Public Limited”.
To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×